CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis

by Berchuck, A., Bjorge, L., Defazio, A., Djedovic, V., Glasspool, R., Goode, E.L, Goodman, M.T, Høgdall, C.K, Høgdall, E., Jensen, A., Johnatty, S.E, Karlan, B.Y, Kjaer, S.K, Lajkosz, K., Lambrechts, D., Lester, J., Matsuo, K., May, T., Modugno, F., Pejovic, T., Riggan, M.J, Roxburgh, P., Schildkraut, J.M, Thompson, P.J, Thomsen, L.C.V, Tone, A., Webb, P.M, Winham, S.J, Wohlmuth, C.
Published 2022

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

by Anton-Culver, H., Berchuck, A., Chang-Claude, J., Cho, K., Cramer, D., Doherty, J.A, Fortner, R.T, Goodman, M.T, Hanley, G.E, Harris, H.R, Jensen, A., Jordan, S.J, Khoja, L., Kjaer, S.K, Lee, A.W, McLean, K., Modugno, F., Moysich, K., Mukherjee, B., Muthukumar, A., Pearce, C.L, Phung, M.T, Pike, M.C, Risch, H., Schildkraut, J.M, Terry, K.L, The Australian Ovarian Cancer Study Group, Webb, P.M, Weber, R.P, Wu, A.H, Ziogas, A.
Published 2022